Tiverton Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Tiverton Asset Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$610K	Hold	12,563	–	–	0.02%	358
2019 Q2	$661K	Sell	12,563 -1,820	-13%	-$105K	0.02%	327
2019 Q1	$762K	Sell	14,383 -10,261	-42%	-$504K	0.03%	274
2018 Q4	$1.01M	Buy	+24,644	New	+$923K	0.06%	176
2018 Q3	–	Sell	-3,683	Closed	-$166K	–	429
2018 Q2	$166K	Buy	+3,683	New	+$168K	0.01%	334

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Tiverton Asset Management's GBT Position: Q3 2019 in Review

Tiverton Asset Management held its Global Blood Therapeutics, Inc. (GBT) position steady in Q3 2019 at 12,563 shares worth $610K. The position accounts for 0.02% of the portfolio, ranked #358.

Tiverton Asset Management first reported a position in GBT in Q2 2018 and has held it in 5 quarters since. The position peaked at $1.01M in Q4 2018. 208 funds tracked by Wall St. Rank hold GBT as of Q3 2019.

Tiverton Asset Management held 12,563 shares of Global Blood Therapeutics, Inc. worth $610K as of Q3 2019.
Tiverton Asset Management left its Global Blood Therapeutics, Inc. share count unchanged in Q3 2019.
Global Blood Therapeutics, Inc. made up 0.02% of Tiverton Asset Management's portfolio in Q3 2019, its #358 holding.
Tiverton Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2018 and has held it in 5 quarters since.
Tiverton Asset Management's Global Blood Therapeutics, Inc. position peaked at $1.01M in Q4 2018.
208 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.